Daniel Rivera

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant

Leyre Bento, José María Bastida, Irene García‐Cadenas et al. · Biology of Blood and Marrow Transplantation · 2019 · 63 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Implications of <scp>RAS</scp> mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes

Daniel Rivera, Kunhwa Kim, Rashmi Kanagal‐Shamanna et al. · American Journal of Hematology · 2022 · 31 citations

Medicine, Hematology, Oncology +15

Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy

Sergio Matarraz, Pilar Leóz, C. Fernández et al. · Modern Pathology · 2018 · 16 citations · Full text

Medicine, Hematology, Oncology +14

Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of<i>TP53</i>alterations and venetoclax treatment

Hussein A. Abbas, Edward Ayoub, Hanxiao Sun et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2022 · 12 citations · Full text

Life Sciences, Hematology, Molecular Genetics +16

Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis

Fadi Haddad, Koji Sasaki, Jayastu Senapati et al. · JCO Oncology Practice · 2024 · 11 citations

Medicine, Hematology, Oncology +15